on 19 Jul 2020
Last Applicant/ Owned by
69120 Heidelberg
DE
Serial Number
79088741 filed on 19th Jul 2010
Registration Number
3995950 registered on 19th Jul 2011
Filing Basis
No Filing Basis
Disclaimer
NO DATA
The mark consists of the stylized term "AGENNIX" wherein the letters "AG" are in turquoise and the letters "ENNIX" are in black. pharmaceutical preparations for the treatment of cancer, sepsis, tumors, skin ulcers and bacterial infection and to modulate the immune system The color(s) turquoise and anthracite is/are claimed as a feature of the mark. scientific research and development services iRead More
pharmaceutical preparations for the treatment of cancer, sepsis, tumors, skin ulcers and bacterial infection and to modulate the immune system
scientific research and development services in the field of chemistry, biotechnology, bio-pharmaceutics and medical science; technology consultation and research in the field of chemistry, biotechnology, bio-pharmaceutics and medical science; chemical, biochemical, biological and bacteriological research and analysis; preparing biotechnological and biopharmaceutical analysis; pharmaceutical drug development services; biological research; scientific research
No 79088741
No Service Mark
No
No
No
No
No
No
No
No
No
The mark consists of the stylized term "AGENNIX" wherein the letters "AG" are in turquoise and the letters "ENNIX" are in black.
| Status Date | Action Taken |
|---|---|
| 07th Aug 2021 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED |
| 07th Aug 2021 | DEATH OF INTERNATIONAL REGISTRATION |
| 15th Dec 2018 | TOTAL INVALIDATION PROCESSED BY THE IB |
| 08th Nov 2018 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
| 08th Nov 2018 | INVALIDATION PROCESSED |
| 23rd Oct 2018 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
| 23rd Feb 2018 | CANCELLED SECTION 71 |
| 03rd Mar 2013 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 16th Nov 2011 | FINAL DISPOSITION PROCESSED |
| 16th Nov 2011 | FINAL DISPOSITION NOTICE SENT TO IB |
